Clough Capital Partners L P Aveo Pharmaceuticals, Inc. Transaction History

Clough Capital Partners L P

  • $924 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$5.12 - $6.89 $536,576 - $722,072
-104,800 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$6.21 - $7.45 $1.21 Million - $1.45 Million
-195,200 Reduced 65.07%
104,800 $691,000
Q1 2021

May 17, 2021
BUY
$5.97 - $15.28 $1.79 Million - $4.58 Million
300,000 New
300,000 $2.2 Million

Others Institutions Holding AVEO

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About AVEO PHARMACEUTICALS, INC.

AVEO Quotes by TradingView
  • Ticker AVEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,676,000
  • Description
  • AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...
More about AVEO
Track This Portfolio

Track Clough Capital Partners L P Portfolio

Follow Clough Capital Partners L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

News

Stay updated on Clough Capital Partners L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email